Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
In the UK, the MHRA has approved semaglutide (Wegovy) and liraglutide (Saxenda) specifically for weight management in adults with obesity or overweight with weight-related comorbidities (as per NICE TA875 and TA664)
Disclosure of interest: Carmen Garca-Cabo, Lorena Benavente Fernndez, Mara Castan Apilanez, Montserrat Gonzlez Delgado, Davinia Larrosa Campo, Elena Lpez-Cancio, Mara Rico Santos, Sergio Calleja Puerta.: nothing to disclose E-Posters - DIAGNOSIS / ETIOLOGY 04.00 - DIAGNOSIS / ETIOLOGY - 04.01 - DIAGNOSIS/INVESTIGATION OF STROKE ETIOLOGY P2383 - ESOC25-1567 REDUCING ACUTE ADVANCED IMAGING BURDEN IN ACUTE NEUROLOGICAL PRESENTATIONS: THE ESSENTIAL ROLE OF TELESTROKE NEUROLOGISTS Shayandokht Taleb 1,2 , Navdeep Sangha 1 , Zahra Ajani 1 , Denise Gaffney 1 , Howard Rho 1 , Jeffrey Saver 2 1 Kaiser Permanente Los Angeles Medical Center, Los Angeles, United States, 2 University of California, Los Angeles, Los Angeles, United States Background and Aims: Stroke mimics account for 5-60% of stroke codes
Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice
Overview of Cardio Fit IV Cardio Fit IV is Desert Mobile Medicals dedicated cardiovascular optimization infusion, engineered to support heart function, circulation, endurance, recovery, and metabolic balance
US$ 28.23
US$ 29.40
US$ 28.41